Elsevier

The Lancet

Volume 361, Issue 9355, 1 February 2003, Pages 393-395
The Lancet

Research Letters
Association between telomere length in blood and mortality in people aged 60 years or older

https://doi.org/10.1016/S0140-6736(03)12384-7Get rights and content

Summary

During normal ageing, the gradual loss of telomeric DNA in dividing somatic cells can contribute to replicative senescence, apoptosis, or neoplastic transformation. In the genetic disorder dyskeratosis congenita, telomere shortening is accelerated, and patients have premature onset of many age-related diseases and early death. We aimed to assess an association between telomere length and mortality in 143 normal unrelated individuals over the age of 60 years. Those with shorter telomeres in blood DNA had poorer survival, attributable in part to a 3·18-fold higher mortality rate from heart disease (95% CI 1·36–7·45, p=0·0079), and an 8·54-fold higher mortality rate from infectious disease (1·52–47·9, p=0·015). These results lend support to the hypothesis that telomere shortening in human beings contributes to mortality in many age-related diseases.

References (5)

  • VulliamyT et al.

    The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita

    Nature

    (2001)
  • SaretzkiG et al.

    Replicative aging, telomeres, and oxidative stress

    Ann N Y Acad Sci

    (2002)
There are more references available in the full text version of this article.

Cited by (1435)

  • Biomarkers in adult spinal deformity surgery

    2023, Seminars in Spine Surgery
  • Quantifying telomere transcripts as tool to improve risk assessment for genetic instability and genotoxicity

    2023, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
View all citing articles on Scopus
View full text